Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumor-only versus paired tumor-normal sequencing
Saved in:
Published in | Haematologica (Roma) Vol. 109; no. 9; pp. 3024 - 3030 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
Fondazione Ferrata Storti
22.02.2024
Ferrata Storti Foundation |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Bibliography: | Disclosures SPH owns common stock in Amgen and has received honoraria or consulting fees from Amgen, Jazz, Novartis, and Servier. SKT has received research funding from Kura Oncology and Incyte Corporation, has served on scientific advisory boards for Aleta Biotherapeutics, AstraZeneca, Jazz Pharmaceuticals, Kura Oncology, and Syndax Pharmaceuticals, and has received travel support from Amgen (all for unrelated studies). All the other authors have no conflicts of interest to disclose. |
---|---|
ISSN: | 0390-6078 1592-8721 |
DOI: | 10.3324/haematol.2023.284855 |